Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study will describe the interplay between the gut hormones GIP and CCK and their regulation of blood flow to the large vessels in patients with Postural Orthostatic Tachycardia Syndrome (POTS) and GIP, CCK and GLP-1 in healthy. This is addressed by hormone infusions during MR-scans of the abdomen and intake of oral glucose.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: t
View:

• Previously diagnosed with POTS in tilt test or active stand-test (either newly diagnosed within last 3 months or in new tilt test/active stand test during screenings visit)

• Reproducible orthostatic intolerance with raise in HR on \>30 bpm when standing within 10 minutes of change of supine to standing in age \>19 years or \>40 bpm in age 18-19 years.

• POTS symptoms/orthostatic intolerance

• Age 18-50

• Waist ratio \<180 cm

• Age 18-50

• Waist ratio \<180 cm

• Matched a POTS patient in age, sex and BMI

Locations
Other Locations
Denmark
Rigshospitalet
RECRUITING
Copenhagen
Contact Information
Primary
Sophie W Nielsen, MD
sophie.nielsen@sund.ku.dk
+ 45 27 26 79 94
Backup
Lærke S Gasbjerg, MD, PhD
lsg@sund.ku.dk
+45 25 34 68 94
Time Frame
Start Date: 2025-03-15
Estimated Completion Date: 2026-09-30
Participants
Target number of participants: 30
Treatments
Active_comparator: Saline
Saline infusion, oral glucose (POTS and healthy)
Experimental: GIP antagonist
GIP(3-30)NH2 infusion, oral glucose (POTS and healthy)
Experimental: GLP-1 antagonist
Exendin(9-39)NH2 infusion, oral glucose (only in healthy)
Experimental: CCK agonist
CCK-8 infusion, oral glucose (POTS and healthy)
Sponsors
Leads: University of Copenhagen
Collaborators: Rigshospitalet, Denmark

This content was sourced from clinicaltrials.gov